{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:37:56Z","timestamp":1792078676429,"version":"4.4.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1023\/a:1015096313594","type":"journal-article","created":{"date-parts":[[2002,12,29]],"date-time":"2002-12-29T14:13:07Z","timestamp":1041171187000},"page":"91-99","source":"Crossref","is-referenced-by-count":16,"title":["Evaluating high dose therapy in Multiple Myeloma: Use of quality-adjusted survival analysis"],"prefix":"10.1007","volume":"11","author":[{"given":"R.","family":"Porcher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"L\u00e9vy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Fermand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Katsahian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Chevret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ph.","family":"Ravaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"2","key":"394243_CR1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199607113350204","volume":"335","author":"M Attal","year":"1996","unstructured":"Attal M, Harousseau JL, Stoppa AM, et al. A Prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in Multiple Myeloma. N Engl J Med 1996; 335(2): 91\u201397.","journal-title":"N Engl J Med"},{"issue":"9","key":"394243_CR2","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1182\/blood.V92.9.3131","volume":"92","author":"JP Fermand","year":"1998","unstructured":"Fermand JP, Ravaud P, Chevret S, et al. High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: Up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial. Blood 1998; 92(9): 3131\u20133136.","journal-title":"Blood"},{"issue":"10Suppl1","key":"394243_CR3","first-page":"402a","volume":"94","author":"JP Fermand","year":"1999","unstructured":"Fermand JP, Ravaud P, Katsahian S, et al. High-dose therapy (HDT) and autologous blood stem cell (ABSC) transplantation vs. conventional treatment in multiple myeloma (MM): Results of a randomized trial in 190 patients 55\u201365 years of age. Blood 1999; 94(10, Suppl 1): 402a.","journal-title":"Blood"},{"issue":"11","key":"394243_CR4","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/sim.4780091106","volume":"9","author":"PP Glasziou","year":"1990","unstructured":"Glasziou PP, Simes RJ, Gelber RD. Quality adjusted survival analysis. Stat Med 1990; 9(11): 1259\u20131276.","journal-title":"Stat Med"},{"key":"394243_CR5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/00031305.1995.10476135","volume":"49","author":"RD Gelber","year":"1995","unstructured":"Gelber RD, Cole BF, Gelber S, Goldhirsch A. Comparing treatments using quality-adjusted survival: The Q-TWiST method. Am Stat 1995; 49: 161\u2013169.","journal-title":"Am Stat"},{"issue":"15","key":"394243_CR6","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/jnci\/88.15.1039","volume":"88","author":"RD Gelber","year":"1996","unstructured":"Gelber RD, Goldhirsch A, Cole BF, Wieand HS, Schroeder G, Krook JE. A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer. J Natl Cancer Inst 1996; 88(15): 1039\u20131045.","journal-title":"J Natl Cancer Inst"},{"issue":"3\u20134","key":"394243_CR7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s002280050378","volume":"53","author":"S Trippoli","year":"1997","unstructured":"Trippoli S, Becagli P, Messori A. Adjuvant cyclophosphamide, methotrexate and fluorouracil for node-positive breast cancer: A lifetime cost-utility analysis based on a modified Q-TWIST method. Eur J Clin Pharmacol 1997; 53(3\u20134): 281\u2013282.","journal-title":"Eur J Clin Pharmacol"},{"issue":"10","key":"394243_CR8","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1200\/JCO.1996.14.10.2666","volume":"14","author":"BF Cole","year":"1996","unstructured":"Cole BF, Gelber RD, Kirkwood JM, Goldhirsch A, Barylak E, Borden E. Quality-of-life-adjusted survival analysis of interferon a-2b adjuvant treatment of high-risk resected cutaneous melanoma: An Eastern Cooperative Oncology Group study. J Clin Oncol 1996; 14(10): 2666\u20132673.","journal-title":"J Clin Oncol"},{"issue":"4","key":"394243_CR9","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0889-8588(05)70025-3","volume":"12","author":"SS Agarwala","year":"1998","unstructured":"Agarwala SS, Kirkwood JM. Adjuvant interferon treatment for melanoma. Hematol Oncol Clin North Am 1998; 12(4): 823\u2013833.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"22","key":"394243_CR10","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1093\/jnci\/88.22.1686","volume":"88","author":"JJ DeCosse","year":"1996","unstructured":"DeCosse JJ, Cennerazzo WJ. Re: A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer. J Natl Cancer Inst 1996; 88(22): 1686.","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl3","key":"394243_CR11","first-page":"81","volume":"32","author":"K Pummer","year":"1997","unstructured":"Pummer K, Lehnert M, Stettner H, Hubmer G. Randomized comparison of total androgen blockade alone vs. combined with weekly epirubicin in advanced prostate cancer. Eur Urol 1997; 32(Suppl 3): 81\u201385.","journal-title":"Eur Urol"},{"issue":"2","key":"394243_CR12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/(SICI)1097-0045(19990201)38:2<100::AID-PROS3>3.0.CO;2-X","volume":"38","author":"I Rosendahl","year":"1999","unstructured":"Rosendahl I, Kiebert GM, Curran D, et al. Quality-adjusted survival (Q-TWiST) analysis of EORTC trial 30853: Comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer. European Organization for Research and Treatment of Cancer. Prostate 1999; 38(2): 100\u2013109.","journal-title":"Prostate"},{"issue":"7","key":"394243_CR13","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1200\/JCO.1998.16.7.2339","volume":"16","author":"BF Cole","year":"1998","unstructured":"Cole BF, Solal-Celigny P, Gelber RD, et al. Quality-of-lifeadjusted survival analysis of interferon a-2b treatment for advanced follicular lymphoma: An aid to clinical decision making. J Clin Oncol 1998; 16(7): 2339\u20132344.","journal-title":"J Clin Oncol"},{"issue":"7","key":"394243_CR14","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1200\/JCO.1999.17.7.2144","volume":"17","author":"SK Parsons","year":"1999","unstructured":"Parsons SK, Gelber S, Cole BF, et al. Quality-adjusted survival after treatment for acute myeloid leukemia in childhood: A Q-TWiST analysis of the pediatric oncology group study 8821. J Clin Oncol 1999; 17(7): 2144\u20132152.","journal-title":"J Clin Oncol"},{"issue":"8","key":"394243_CR15","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1200\/JCO.1998.16.8.2834","volume":"16","author":"B Zee","year":"1998","unstructured":"Zee B, Cole B, Li T, et al. Quality-adjusted time without symptoms or toxicity analysis of interferon maintenance in multiple myeloma. J Clin Oncol 1998; 16(8): 2834\u20132839.","journal-title":"J Clin Oncol"},{"issue":"3","key":"394243_CR16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1023\/A:1008827424392","volume":"8","author":"CE Schwartz","year":"1999","unstructured":"Schwartz CE, Mathias SD, Pasta DJ, et al. A comparison of two approaches for assessing patient importance weights to conduct an Extended Q-TWiST analysis. Qual Life Res 1999; 8(3): 197\u2013207.","journal-title":"Qual Life Res"},{"issue":"7212","key":"394243_CR17","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/bmj.319.7212.753","volume":"319","author":"G Elwyn","year":"1999","unstructured":"Elwyn G, Edwards A, Gwyn R, Grol R. Towards a feasible model for shared decision making: Focus group study with general practice registrars. Br Med J 1999; 319(7212): 753\u2013756.","journal-title":"Br Med J"},{"issue":"7212","key":"394243_CR18","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/bmj.319.7212.780","volume":"319","author":"C Charles","year":"1999","unstructured":"Charles C, Whelan T, Gafni A. What do we mean by partnership in making decisions about treatment? Br. Med J 1999; 319(7212): 780\u2013782.","journal-title":"Br. Med J"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1015096313594.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1015096313594\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1015096313594.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T04:42:39Z","timestamp":1754455359000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1015096313594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["394243"],"URL":"https:\/\/doi.org\/10.1023\/a:1015096313594","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}